News

Allstate has outperformed its industry peers recently, and analysts remain moderately optimistic about the stock’s prospects.

MetLife, Globe Life, and Unum Group are hitting 52-week highs as P&C premiums decline, rewarding insurers with life, group benefits, and health exposure.

Chubb stock: setting the stage Chubb (CB) has drawn investor attention after recent trading put the stock at $326.27, with returns of 3.7% over the past week and 2.1% over the past month. See our latest analysis for Chubb. The recent 3.7% 1 day share price return and 4.7% 7 day share price return sit alongside a 5.2% year to date share price gain. The 1 year total shareholder return of 12.5% points to momentum that has been building rather than fading. If this kind of steady compounding...

American Financial benefits from a large investment portfolio, with rising yields and invested assets helping drive earnings growth.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.

Chubb (NYSE:CB) has approved a 5.2% increase in its annual dividend, marking the 33rd consecutive yearly raise. The company also authorized a new $7.5b share repurchase program as part of its capital return approach. These actions highlight ongoing efforts to return capital to shareholders through both dividends and buybacks. For investors watching Chubb at a share price of $312.27, the latest capital return moves come after a mixed run in the stock. Shares are up 6.7% over the past year...

While Chubb has underperformed its industry peers recently, analysts remain moderately optimistic about the stock’s prospects.

Chubb Limited is leveraging acquisitions, premium growth and rising investment income to drive long-term growth.

Chubb Limited (NYSE:CB) is included among the 15 Best Dividend Paying Stocks to Buy Right Now. On May 26, Piper Sandler increased its price recommendation on Chubb Limited (NYSE:CB) to $340 from $328. It reiterated a Neutral rating on the stock. The firm pointed to recent share performance and the passage of time as factors […]

Chubb Limited (NYSE:CB) is one of the 12 Undervalued Financial Stocks to Buy Now. On May 26, 2026, Piper Sandler raised the firm’s price target on Chubb Limited (NYSE:CB) to $340 from $328 and maintained a Neutral rating on the shares. Piper Sandler cited recent stock performance and the roll-forward of time. The firm said […]

AIZ is using AI, automation and digital platforms to improve claims, device lifecycle management and customer experience across its businesses.

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the multi-line insurance stocks, including Chubb (NYSE:CB) and its peers.

Berkshire Hathaway's insurance float fuels investments as the company shifts to Japan trading houses and builds BHE renewables, backed by $370B+ cash.

Chubb (CB) has put shareholder returns in the spotlight after its 2026 Annual General Meeting, with investors approving a 5.2% dividend increase and the Board authorizing a new US$7.5b share repurchase program. See our latest analysis for Chubb. The dividend and buyback news comes as Chubb’s share price has gained 5.8% year to date. The 1 year total shareholder return of 16.1% and 5 year total shareholder return of 108.1% point to momentum that has built over time. If this kind of steady...

Earlier in May 2026, Chubb Limited shareholders approved a 5.2% dividend increase to US$4.08 annually and authorized a US$7.50 billion share repurchase program with no expiration, while a subsidiary issued US$1.00 billion of 5.30% senior notes due 2036 guaranteed by the parent. Alongside these capital actions, Chubb’s Canadian benefits unit launched Combined Cancer Care, a supplemental insurance product aimed at easing the substantial non-medical financial burden faced by cancer patients and...

Chubb Limited raises its dividend for the 33rd straight year and approved a new $7.5B buyback plan, underscoring confidence in cash flow and capital strength.

Financial stocks were higher in late Thursday afternoon trading, with the NYSE Financial Index up 0.

Financial stocks were mixed in Thursday afternoon trading, with the NYSE Financial Index fractionall

Although Chubb Limited has underperformed the SPX over the past 52 weeks, Wall Street analysts remain moderately optimistic about the stock's prospects.

Chubb (NYSE:CB) has launched a new cancer care insurance product in Canada, expanding its presence in the supplemental health insurance market. The company has also received strong credit ratings from AM Best on new senior unsecured bonds issued in Hong Kong. These moves highlight Chubb's activity in both product expansion and global capital markets, with potential implications for its international footprint. Chubb enters this news cycle with its stock at $320.09 and a return of 66.3% over...

MCY backs BurnBot to advance wildfire mitigation efforts, aiming to improve underwriting stability and insurance availability in high-risk areas.

TRV's growing investment income helps offset underwriting pressure and support earnings growth.

Recently, Zacks.com users have been paying close attention to Chubb (CB). This makes it worthwhile to examine what the stock has in store.

Chubb Limited is betting big on AI and digital transformation, targeting lower costs, automated processes, and stronger underwriting profitability.

Understanding Chubb stock after recent performance Chubb (CB) has seen its share price move lower over the past week, month, and past 3 months, with its most recent close at $321.28, prompting investors to reassess what the current valuation reflects. See our latest analysis for Chubb. While the recent 7 day and 90 day share price returns of 1.75% and 2.93% respectively point to fading short term momentum, Chubb’s 1 year and 5 year total shareholder returns of 12.63% and 105.30% highlight a...

Markel has improving insurance operations, a sizable equity portfolio, and a low valuation relative to specialty insurance peers.

PLMR beat Q1 estimates as revenues jump 58.7% on higher premiums and investment income despite rising expenses and weaker underwriting income.

MCY swings to profit in Q1 with an earnings beat, fueled by strong premiums, lower catastrophe losses and improved expenses.

AXS beats Q1 estimates as underwriting income climbs and premiums grow, offsetting weaker investment income and higher expenses.